A polysomnographic placebo-controlled evaluation of the efficacy and safety of eszopiclone relative to placebo and zolpidem in the treatment of primary insomnia.
Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.
A polysomnography study of eszopiclone in elderly patients with insomnia.
An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults.
A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia.
Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia.